Challenging the standard of care in advanced melanoma: focus on pembrolizumab
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Management and Research"
DOI: 10.2147/cmar.s92546
Abstract: The last several years have seen a dramatic rise in the number of effective therapies that have been shown to improve survival outcomes for patients with advanced melanoma. Among these treatments are the immune checkpoint… read more here.
Keywords: focus pembrolizumab; advanced melanoma; challenging standard; melanoma focus ... See more keywords